Rani Therapeutics develops the RaniPill capsule, an oral delivery technology for drugs and biologics that are now often given by injection. It last closed at $0.56 on Nov 17, up 3.54% on the day.
Only 1 firm rated RANI in the past 90 days, not enough for a consensus
Average 12-month target
$6.00
▲ 972.6% upside
Based on 1 analyst who set a price target on RANI in the past 90 days. The average target is $6.00, with a high of $6.00 and a low of $6.00, compared with the last close of $0.56.
Low $6.00Avg $6.00High $6.00
Blue marker: last close $0.56
Highest target$6.00
Average target$6.00
Lowest target$6.00
Latest rating changes
Chardan CapitalMaintained
Oct 22Buy$6
Chardan CapitalInitiated
Aug 18Buy$6
Canaccord GenuityMaintained
May 20Buy$5
Date
Firm
Action
Rating
Price target
Oct 22
Chardan Capital
Maintained
Buy
$6
Aug 18
Chardan Capital
Initiated
Buy
$6
May 20
Canaccord Genuity
Maintained
Buy
$5
Loading…
Technical Analysis
RANI · as of the Nov 17 close · updated after every close
Downtrend
The stock is 2% below its 20 day and 24% below its 50 day average. It is 58% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 42). The nearest support is the Pivot S1 at $0.54, and the nearest resistance the Pivot at $0.56.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityNormal, 7.6%/day
Key levels
$1.9952 week high+255.4%
$0.89200 day average+58.9%
$0.82Swing high (Aug 12)+46.4%
$0.74100 day average+32.1%
$0.6950 day average+23.2%
$0.58Pivot R1+3.6%
$0.5720 day average+1.8%
$0.56Pivot+0.0%
$0.56Last close
$0.54Pivot S1−3.6%
$0.51Swing low (Nov 5)−8.9%
$0.5052 week low−10.7%
Indicators
RSI (14)
41.51
Middle of its range
Neutral
MACD
-0.04
Above its signal line
Bullish
Stochastic
34.0
Middle of its range
Neutral
ADX (14)
45.3
Strong downtrend
Williams %R
-49.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
-40.5
Oversold below −100, overbought above 100
Neutral
Rate of change
+0.7%
Change over 10 sessions
Bullish
ATR (14)
$0.04
Typical daily range, 7.7% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 21.9%/day
Key levels
$1.9952 week high+255.4%
$0.89200 day average+58.9%
$0.82Swing high (Aug 12)+46.4%
$0.74100 day average+32.1%
$0.6950 day average+23.2%
$0.58Pivot R1+3.6%
$0.5720 day average+1.8%
$0.56Pivot+0.0%
$0.56Last close
$0.54Pivot S1−3.6%
$0.51Swing low (Nov 5)−8.9%
$0.5052 week low−10.7%
Indicators
RSI (14)
35.43
Weak, oversold below 30
Neutral
MACD
-0.10
Below its signal line
Bearish
Stochastic
9.3
Near the bottom of its range
Oversold
ADX (14)
15.7
No clear trend
Williams %R
-86.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-130.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−33.6%
Change over 10 sessions
Bearish
ATR (14)
$0.12
Typical daily range, 21.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for RANI
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RANI did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow RANI usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How RANI has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RANI is in one of them and how their past RANI trades turned out.
Rani Therapeutics is a biotherapeutics company based in San Jose, California. It is developing the RaniPill capsule, a delivery technology designed to let drugs and biologics such as antibodies and peptides be taken orally instead of by injection. The company is advancing its own oral drug candidates and is seeking partnerships with biopharmaceutical companies to use its technology. Its intended customers include patients, physicians, and healthcare systems, and it has no approved products for sale yet.